台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    78.5
  • 漲跌
    ▲3.5
  • 漲幅
    +4.67%
  • 成交量
    512
  • 產業
    上櫃 生技醫療類股▲1.01%
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-華南永昌-內壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-內壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/0800.001078.0078.20-10267-3.74%
2024/04/2900.00167.4067.50-1252-0.40%
2024/04/2200.001065.8064.50-10253-3.94%
2024/03/0100.00154.3054.80-1183-0.54%
2024/02/1500.000.455.5055.50-0.4177-0.22%
2024/02/0500.001050.7050.50-10164-6.08%
2024/01/2300.001040.1039.95-10148-6.74%
2023/12/2700.00541.5041.50-5237-2.10%
2023/12/2000.001040.0039.75-10231-4.32%
2023/12/1800.00539.5039.50-5229-2.17%
2023/12/0600.00141.0040.10-1212-0.47%
2023/12/01241.2000.0040.0022100.95%
2023/11/28241.3500.0041.9522030.98%
2023/11/2100.00542.8542.50-5185-2.69%
2023/11/1700.00240.0039.90-2177-1.12%
2023/11/1600.00539.5039.30-5175-2.85%
2023/11/1500.00535.5036.45-5163-3.06%
2023/11/1400.001.434.2234.90-1.4158-0.88%
2023/11/03230.4500.0030.0021401.42%
2023/10/2700.001734.1032.40-17122-13.90%
2023/10/2600.001031.3731.00-1096-10.33%
2023/07/1300.00923.0522.90-980-11.20%
2023/05/240.121.5000.0021.650.11120.09%
2023/04/0600.00120.1520.00-193-1.07%
2023/03/2200.00220.2020.40-264-3.11%
2023/03/21120.0000.0019.201621.61%
2022/04/2500.00115.3015.30-1127-0.79%
2022/04/18115.7000.0016.951921.08%
2022/01/2500.00115.4515.45-1123-0.81%
2021/12/2200.00116.6016.45-1117-0.85%
2021/12/17116.4500.0016.2011110.90%
2021/08/2300.00215.6515.65-2143-1.39%
2021/07/15215.6500.0015.7523980.50%
2021/07/08316.3500.0016.1034150.72%
2021/06/29115.6000.0015.6014710.21%
2021/06/22115.5500.0015.5514740.21%
2021/06/21116.0000.0015.7014760.21%
2021/06/16116.45116.4516.4504770.00%
2021/06/11116.6500.0016.9014770.21%
2021/05/25116.6000.0016.5515310.19%
2021/05/1700.00219.5519.60-2506-0.40%
2021/05/1300.00519.0719.55-5434-1.15%
2021/05/12317.8000.0017.8033770.79%
2021/04/22217.1300.0017.2523420.58%
2021/04/1300.00219.2018.20-2322-0.62%
2021/04/12118.20118.8018.8002940.00%
2021/03/19216.4000.0016.2022690.74%
2021/03/09117.2000.0016.9012710.37%
2021/03/0500.00518.0017.85-5265-1.88%
2021/03/03217.2500.0017.3522600.77%
2021/02/2600.00118.1518.15-1230-0.43%
2021/02/2300.00118.5017.45-1193-0.52%
2021/02/2200.00217.4017.60-2176-1.13%
2020/12/15517.0000.0016.9053491.43%
2020/12/07218.0000.0017.9023640.55%
2020/12/0300.00118.7018.60-1368-0.27%
2020/11/201018.8500.0019.05103822.62%
2020/11/11520.7500.0020.3054251.17%
2020/10/23219.60319.8019.70-1548-0.18%
2020/10/2100.00221.7521.75-2544-0.37%
2020/10/20119.7000.0019.8015460.18%
2020/10/1900.00218.0018.00-2557-0.36%
2020/10/16216.0000.0016.4026020.33%
2020/10/06217.0500.0017.1021,0750.19%
2020/09/2500.00116.7516.60-11,320-0.08%
2020/09/23118.1000.0018.0011,3350.07%
2020/09/2100.00218.8018.75-21,350-0.15%
2020/09/1700.00118.8018.60-11,362-0.07%
2020/09/15219.1000.0019.1521,3770.15%
2020/09/11118.0500.0018.1011,4170.07%
2020/09/0800.00219.8519.95-21,649-0.12%
2020/09/07419.4800.0019.2041,7080.23%
2020/09/0200.00120.7520.35-11,877-0.05%
2020/08/2800.00121.1020.85-11,910-0.05%
2020/08/2700.00420.7820.55-41,922-0.21%
2020/08/26420.9800.0020.9541,9400.21%
2020/08/19322.07222.4521.8012,1280.05%
2020/08/18222.5000.0022.2022,1780.09%
2020/08/11123.0000.0022.6012,3220.04%
2020/08/0600.00224.7024.30-22,302-0.09%
2020/08/0300.00124.8526.40-12,273-0.04%
2020/07/29124.6500.0025.5512,2730.04%
2020/07/28223.6000.0023.4022,2650.09%
2020/07/22129.9000.0030.0012,2040.05%
2020/07/2100.00227.3827.45-22,149-0.09%
2020/07/20223.60125.7525.0012,1090.05%
2020/07/17126.7000.0026.1512,0680.05%
2020/07/16129.3000.0029.0512,0180.05%
2020/07/15130.55231.0030.80-11,983-0.05%
2020/07/14631.911030.6229.60-41,907-0.21%
2020/07/13530.4300.0031.5551,7930.28%
2020/07/10627.669528.6628.70-891,666-5.34%
2020/07/09126.1000.0026.1011,5300.07%
2020/07/08322.4000.0023.7531,5160.20%
2020/07/03223.6500.0024.2021,4340.14%
2020/06/17125.2000.0025.3511,3500.07%
2020/06/1500.002123.6324.20-211,207-1.74%
2020/06/1200.00220.7022.00-21,124-0.18%
2020/06/11121.00820.7921.00-71,077-0.65%
2020/06/10517.95218.3519.1039850.30%
2020/06/0900.00317.8517.40-3958-0.31%
2020/06/08317.6200.0018.0039460.32%
2020/06/0500.00217.1017.30-2945-0.21%
2020/06/04217.3000.0017.0029550.21%
2020/06/01318.1200.0017.7039680.31%
2020/05/29218.6500.0018.5029730.21%
2020/05/2800.00818.4418.50-8978-0.82%
2020/05/27422.68123.7519.4539470.32%
2020/05/26221.6000.0021.6029020.22%
2020/05/25319.00219.6519.6519350.11%
2020/05/22217.90217.9017.9009300.00%
2020/03/0500.001015.3514.35-10482-2.07%
2020/03/041015.1500.0014.95104592.18%
2020/03/0200.00114.1514.60-1397-0.25%
2020/02/26113.8500.0014.0513210.31%
2020/02/2400.00211.6511.65-2218-0.91%
2020/01/3100.00211.3011.05-2136-1.46%
2020/01/30211.7000.0011.7521281.56%
2020/01/17210.8000.0010.7021061.87%
2020/01/0700.00110.4010.45-1101-0.98%
2020/01/0219.7000.0010.851791.26%
2019/06/1100.0009.769.670960.00%
2019/04/22212.2000.0012.1521421.40%
2019/03/2100.00112.4512.50-1146-0.68%
2019/03/15113.20112.8512.9001450.00%
2019/03/14112.95213.2813.40-1138-0.72%
2019/03/08012.5000.0012.4001300.00%
2019/03/06112.0500.0012.1011280.78%
2019/02/25112.1000.0012.0011240.80%
2019/01/1500.00913.2713.40-9101-8.87%
2019/01/14913.945013.9014.00-4194-43.55%
2019/01/115012.89912.9012.90417554.66%
2019/01/09812.0500.0011.6086711.92%
2018/12/171311.2000.0011.25136320.57%
2018/11/26112.2000.0012.201851.17%
2018/11/1300.00113.3013.20-186-1.16%
2018/10/301311.1400.0011.30139014.42%
2018/10/251613.1300.0012.35168818.03%
2018/09/251316.7000.0016.801311711.05%
2018/09/12117.0000.0016.8511210.82%
2018/09/1000.00118.4518.45-1112-0.89%
2018/07/032017.4000.0017.35204014.99%
2018/05/291118.0900.0017.95113902.82%
2018/04/2700.00219.9519.60-2377-0.53%
2018/04/25319.9300.0019.8033700.81%
2018/04/16121.3500.0021.3513290.30%
2018/04/1300.00724.1023.70-7302-2.32%
2018/04/11421.8900.0022.9042321.72%
2018/04/10322.85122.8522.8521891.05%
2018/01/0900.00818.0018.15-8188-4.25%
2018/01/03419.0000.0018.7541812.20%
2018/01/02220.1000.0019.7521741.15%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音